Abstract
Placebo analgesia is mediated by both opioid and nonopioid mechanisms, but so far nothing is known about the nonopioid component. Here we show that the specific CB1 cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (rimonabant or SR141716) blocks nonopioid placebo analgesic responses but has no effect on opioid placebo responses. These findings suggest that the endocannabinoid system has a pivotal role in placebo analgesia in some circumstances when the opioid system is not involved.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Benedetti, F. Annu. Rev. Pharmacol. Toxicol. 48, 33–60 (2008).
Price, D.D., Finniss, D.G. & Benedetti, F. Annu. Rev. Psychol. 59, 565–590 (2008).
Enck, P., Benedetti, F. & Schedlowski, M. Neuron 59, 195–206 (2008).
Finniss, D.G., Kaptchuk, T.J., Miller, F. & Benedetti, F. Lancet 375, 686–695 (2010).
Amanzio, M. & Benedetti, F. J. Neurosci. 19, 484–494 (1999).
Zubieta, J.K. et al. J. Neurosci. 25, 7754–7762 (2005).
Benedetti, F., Pollo, A. & Colloca, L. J. Neurosci. 27, 11934–11939 (2007).
Petrovic, P., Kalso, E., Petersson, K.M. & Ingvar, M. Science 295, 1737–1740 (2002).
Wager, T.D. et al. Science 303, 1162–1167 (2004).
Eippert, F., Finsterbusch, J., Bingel, U. & Büchel, C. Science 326, 404 (2009).
Guo, J.-Y., Wang, J.-Y. & Luo, F. J. Psychopharmacol. 24, 1561–1567 (2010).
Shimizu, T. Annu. Rev. Pharmacol. Toxicol. 49, 123–150 (2009).
Fowler, C.J. Br. J. Pharmacol. 152, 594–601 (2007).
Rouzer, C.A. & Marnett, L.J. J. Biol. Chem. 283, 8065–8069 (2008).
Hamza, M. & Dionne, R.A. Curr. Mol. Pharmacol. 2, 1–14 (2009).
Horti, A.G. et al. J. Nucl. Med. 47, 1689–1696 (2006).
Wong, D.F. et al. Neuroimage 52, 1505–1513 (2010).
de la Fuente–Fernández, R. et al. Science 293, 1164–1166 (2001).
Scott, D.J. et al. Neuron 55, 325–336 (2007).
Benedetti, F., Amanzio, M. & Maggi, G. Lancet 346, 1231 (1995).
Acknowledgements
This work was supported by grants from Istituto San Paolo di Torino and Regione Piemonte (Turin, Italy) and from the Volkswagen Foundation (Hannover, Germany).
Author information
Authors and Affiliations
Contributions
F.B. planned and conducted the experiments, analyzed the data and wrote the manuscript. M.A. and R.R. analyzed the data and contributed to the writing of the manuscript. C.B. conducted the experiments and contributed to the writing of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figure 1, Supplementary Tables 1–4 and Supplementary Methods (PDF 214 kb)
Rights and permissions
About this article
Cite this article
Benedetti, F., Amanzio, M., Rosato, R. et al. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med 17, 1228–1230 (2011). https://doi.org/10.1038/nm.2435
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2435
- Springer Nature America, Inc.
This article is cited by
-
Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome
Nature Reviews Gastroenterology & Hepatology (2023)
-
Placeboeffekte in der Schmerztherapie
Der Schmerz (2023)
-
Placebo administration for dry eye disease: a level I evidence based systematic review and meta-analysis
International Journal of Clinical Pharmacy (2022)
-
Neurobiologische und neurochemische Mechanismen der Placeboanalgesie
Der Schmerz (2022)
-
Assessing the Impact of Expectations in Cognitive Training and Beyond
Journal of Cognitive Enhancement (2021)